ID

35067

Description

Immunotherapy Combined With Capecitabine Versus Capecitabine Monotherapy in Advanced Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02491697

Lien

https://clinicaltrials.gov/show/NCT02491697

Mots-clés

Versions (1)
  1. 13/02/2019 13/02/2019 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

13 février 2019

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Breast Cancer NCT02491697

Anglais

Eligibility Breast Cancer NCT02491697

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically confirmed with advanced breast cancer.
Description

Advanced breast cancer

Type de données

boolean

Alias
UMLS CUI [1]
C3495917
eastern cooperative oncology group (ecog) performance status was 0 - 2.
Description

ECOG performance status

Type de données

boolean

Alias
UMLS CUI [1]
C1520224
hemoglobin≥10.0g/dl, neutrophil count≥1.5×10^9/l, platelet count≥75×10^9/l; total bilirubin(tbil)≤1.5×uln; alkaline phosphatase(akp), aspartate aminotransferase(ast),alt≤2.5×uln(without metastasis of the liver), akp,ast,alt≤5×uln(with metastasis of the liver); bun≤1.5×uln, cr≤1.5×uln.
Description

Hemoglobin measurement | Neutrophil count | Platelet Count measurement | Serum total bilirubin measurement | Alkaline phosphatase measurement | Aspartate aminotransferase measurement | Alanine aminotransferase measurement | Secondary malignant neoplasm of liver Absent | Secondary malignant neoplasm of liver | Blood urea nitrogen measurement | Creatinine measurement, serum

Type de données

boolean

Alias
UMLS CUI [1]
C0518015
UMLS CUI [2]
C0200633
UMLS CUI [3]
C0032181
UMLS CUI [4]
C1278039
UMLS CUI [5]
C0201850
UMLS CUI [6]
C0201899
UMLS CUI [7]
C0201836
UMLS CUI [8,1]
C0494165
UMLS CUI [8,2]
C0332197
UMLS CUI [9]
C0494165
UMLS CUI [10]
C0005845
UMLS CUI [11]
C0201976
patient received 1-2 kinds of cytotoxic chemotherapy previously.
Description

Cytotoxic Chemotherapy Kind Quantity

Type de données

boolean

Alias
UMLS CUI [1,1]
C0677881
UMLS CUI [1,2]
C0332307
UMLS CUI [1,3]
C1265611
patient never received capecitabine or other oral fluorouracil.
Description

Capecitabine Absent | Fluorouracil Oral Product Absent

Type de données

boolean

Alias
UMLS CUI [1,1]
C0671970
UMLS CUI [1,2]
C0332197
UMLS CUI [2,1]
C3215189
UMLS CUI [2,2]
C0332197
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients who are suffering from serious organ dysfunction.
Description

Organ dysfunction Serious

Type de données

boolean

Alias
UMLS CUI [1,1]
C0349410
UMLS CUI [1,2]
C0205404
hiv positive or other immunodeficiency disease.
Description

HIV Seropositivity | Immunodeficiency

Type de données

boolean

Alias
UMLS CUI [1]
C0019699
UMLS CUI [2]
C0021051
patients who had used long time or are using immunosuppressant drugs.
Description

Immunosuppressive Agents

Type de données

boolean

Alias
UMLS CUI [1]
C0021081
patients who had active infection.
Description

Communicable Disease

Type de données

boolean

Alias
UMLS CUI [1]
C0009450
patients who were allergic to fluorouracil.
Description

Fluorouracil allergy

Type de données

boolean

Alias
UMLS CUI [1]
C0570698
pregnant or lactating women.
Description

Pregnancy | Breast Feeding

Type de données

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
history of other malignancies.
Description

Cancer Other

Type de données

boolean

Alias
UMLS CUI [1]
C1707251
other situations that the researchers considered unsuitable for this study.
Description

Social situation Study Subject Participation Status Inappropriate

Type de données

boolean

Alias
UMLS CUI [1,1]
C0748872
UMLS CUI [1,2]
C2348568
UMLS CUI [1,3]
C1548788
Retour au début de la page

Similar models

Eligibility Breast Cancer NCT02491697

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Advanced breast cancer
Item
histologically confirmed with advanced breast cancer.
boolean
C3495917 (UMLS CUI [1])
ECOG performance status
Item
eastern cooperative oncology group (ecog) performance status was 0 - 2.
boolean
C1520224 (UMLS CUI [1])
Hemoglobin measurement | Neutrophil count | Platelet Count measurement | Serum total bilirubin measurement | Alkaline phosphatase measurement | Aspartate aminotransferase measurement | Alanine aminotransferase measurement | Secondary malignant neoplasm of liver Absent | Secondary malignant neoplasm of liver | Blood urea nitrogen measurement | Creatinine measurement, serum
Item
hemoglobin≥10.0g/dl, neutrophil count≥1.5×10^9/l, platelet count≥75×10^9/l; total bilirubin(tbil)≤1.5×uln; alkaline phosphatase(akp), aspartate aminotransferase(ast),alt≤2.5×uln(without metastasis of the liver), akp,ast,alt≤5×uln(with metastasis of the liver); bun≤1.5×uln, cr≤1.5×uln.
boolean
C0518015 (UMLS CUI [1])
C0200633 (UMLS CUI [2])
C0032181 (UMLS CUI [3])
C1278039 (UMLS CUI [4])
C0201850 (UMLS CUI [5])
C0201899 (UMLS CUI [6])
C0201836 (UMLS CUI [7])
C0494165 (UMLS CUI [8,1])
C0332197 (UMLS CUI [8,2])
C0494165 (UMLS CUI [9])
C0005845 (UMLS CUI [10])
C0201976 (UMLS CUI [11])
Cytotoxic Chemotherapy Kind Quantity
Item
patient received 1-2 kinds of cytotoxic chemotherapy previously.
boolean
C0677881 (UMLS CUI [1,1])
C0332307 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
Capecitabine Absent | Fluorouracil Oral Product Absent
Item
patient never received capecitabine or other oral fluorouracil.
boolean
C0671970 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C3215189 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
Item Group
C0680251 (UMLS CUI)
Organ dysfunction Serious
Item
patients who are suffering from serious organ dysfunction.
boolean
C0349410 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
HIV Seropositivity | Immunodeficiency
Item
hiv positive or other immunodeficiency disease.
boolean
C0019699 (UMLS CUI [1])
C0021051 (UMLS CUI [2])
Immunosuppressive Agents
Item
patients who had used long time or are using immunosuppressant drugs.
boolean
C0021081 (UMLS CUI [1])
Communicable Disease
Item
patients who had active infection.
boolean
C0009450 (UMLS CUI [1])
Fluorouracil allergy
Item
patients who were allergic to fluorouracil.
boolean
C0570698 (UMLS CUI [1])
Pregnancy | Breast Feeding
Item
pregnant or lactating women.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Cancer Other
Item
history of other malignancies.
boolean
C1707251 (UMLS CUI [1])
Social situation Study Subject Participation Status Inappropriate
Item
other situations that the researchers considered unsuitable for this study.
boolean
C0748872 (UMLS CUI [1,1])
C2348568 (UMLS CUI [1,2])
C1548788 (UMLS CUI [1,3])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial